Niyati Desai
Overview
Explore the profile of Niyati Desai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1966
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desai N, Towne W, Connelly C, Baskota S, Crapanzano J, Desai K, et al.
Diagn Cytopathol
. 2025 Mar;
PMID: 40028696
Background: Screening for cervical cancer may include cervical cytology and/or high-risk human papillomavirus testing (HPV). The FDA (Food and Drug Administration)-approved CINtec PLUS dual stain (DS) for p16 and Ki-67...
2.
Connelly C, Towne W, Desai N, Smithgall M, Cimic A, Baskota S
J Am Soc Cytopathol
. 2024 Sep;
13(6):413-419.
PMID: 39341739
Introduction: Pancreaticobiliary carcinomas rarely harbor targetable genetic alterations, including microsatellite instability (MSI) or neurotrophic tyrosine receptor kinase (NTRK) gene fusions. As these malignancies are typically present at an advanced stage...
3.
Desai N, DAmbrosio D, Dombrowski K, Illei P, Heymann J
Surg Pathol Clin
. 2024 Aug;
17(3):411-429.
PMID: 39129140
With the advancement of tissue procurement techniques, in-depth knowledge of morphology is crucial for cytopathologists to diagnose neoplastic and nonneoplastic lung diseases optimally. Cytopathologists must also be well versed in...
4.
Heymann J, DAmbrosio D, Dombrowski K, Desai N, Illei P
Surg Pathol Clin
. 2024 Aug;
17(3):395-410.
PMID: 39129139
Small biopsies of lung are routinely obtained by many methods, including several that result in cytologic specimens. Because lung cancer is often diagnosed at a stage for which primary resection...
5.
Desai N, Connelly C, Sung S, Cimic A, Baskota S
Diagn Cytopathol
. 2024 Aug;
52(12):722-730.
PMID: 39126228
Background: Approximately, 55% of breast carcinomas are reported to be HER-2 low breast carcinomas. Trastuzumab-Deruxtecan is a new FDA-approved targeted therapy for HER-2 low metastatic breast carcinomas, making it essential...
6.
Connelly C, Desai N, Cimic A, Gonzalez A, Baskota S
Diagn Cytopathol
. 2024 May;
52(9):511-518.
PMID: 38808690
Background: Ocular cytology is an effective method of diagnosing infective, benign, and malignant ocular disease processes due to easy accessibility and rapid turnaround time. However, these specimens pose significant diagnostic...
7.
Desai N, Kudose S, Remotti H, Del Portillo A, Fazlollahi L, Lee M, et al.
Virchows Arch
. 2023 Nov;
484(1):61-69.
PMID: 37924345
Hemophagocytic lymphohistiocytosis (HLH) is a rare disease with high mortality. Liver involvement is common (based on elevated liver function tests) with most patients demonstrating acute hepatitis. Liver biopsies are frequently...
8.
Desai N, Green D, Kristan J, Cimic A, Baskota S
Diagn Cytopathol
. 2022 Nov;
51(1):98-100.
PMID: 36369992
No abstract available.
9.
Micalizzi D, Che D, Nicholson B, Edd J, Desai N, Lang E, et al.
Proc Natl Acad Sci U S A
. 2022 Oct;
119(43):e2209563119.
PMID: 36256815
The successful application of antibody-based therapeutics in either primary or metastatic cancer depends upon the selection of rare cell surface epitopes that distinguish cancer cells from surrounding normal epithelial cells....
10.
Porter R, Sun S, Flores M, Berzolla E, You E, Phillips I, et al.
J Clin Invest
. 2022 Jun;
132(16).
PMID: 35708912
Aberrant expression of viral-like repeat elements is a common feature of epithelial cancers, and the substantial diversity of repeat species provides a distinct view of the cancer transcriptome. Repeatome profiling...